Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XNH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain division on July 11, 2025. The delivery order, issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive positioning as an established woman-owned small business in federal pharmaceutical procurement. Performance is scheduled for completion by August 1, 2025, with fulfillment occurring at the vendor's Park Ridge, Illinois location.
This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, particularly for the Defense Logistics Agency's SPE2DB program. The company's contract portfolio demonstrates consistent success in providing specialized pharmaceutical products, including biologics and specialty medications, to military health facilities nationwide. Stelara, an immunosuppressant biologic used in treating inflammatory conditions, represents the type of high-value pharmaceutical product that the company regularly distributes through its federal contracts to support military healthcare operations and medical supply requirements across Department of Defense facilities.
Quick answers
Who was awarded contract SPE2DX25F6XNH?
SPE2DX25F6XNH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 11, 2025.
How much is contract SPE2DX25F6XNH worth?
The government has obligated $16,250 on SPE2DX25F6XNH.
Is contract SPE2DX25F6XNH an order under another contract?
Yes. SPE2DX25F6XNH is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XNH competed?
The extent of competition for SPE2DX25F6XNH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award